Results 161 to 170 of about 23,676 (191)

<i>EML4::RET</i>, a novel transcript fusion in papillary thyroid cancer. [PDF]

JCEM Case Rep
Ciappuccini R, Leman R, Castera L, Dorbeau M, Le Hénaff V, Bardet S.   +5 more
europepmc   +1 more source

Asymptomatic Medullary Thyroid Carcinoma With Isolated Carcinoembryonic Antigen Elevation in a Patient With Chronic Kidney Disease: A Case Report. [PDF]

Clin Case Rep
Altınyüzük O, Ediz B, Yalın SF, Parmaksız E.   +3 more
europepmc   +1 more source

Thyroid Cancer: From Potential Drivers to Real Modulators. [PDF]

Cancers (Basel)
Rafiqi SI, Jaume JC.
europepmc   +1 more source

Real-World Outcomes of Fusion-Directed Targeted Therapy in Advanced Non-Small Cell Lung Cancer Harboring Actionable Gene Fusions. [PDF]

Int J Mol Sci
Delgado Leon F, de Armas SA, Molina M, Morales EG, Fernandez-Gomez M, Raez LE.   +5 more
europepmc   +1 more source

Targeted therapy in thyroid cancer: molecular alterations and clinical management. [PDF]

Front Endocrinol (Lausanne)
Yang Y, Zhang Y, Xu Y, Gu X, Lou N, Ye G.   +5 more
europepmc   +1 more source

Selpercatinib versus multi-kinase inhibitors for advanced medullary thyroid cancer: A network meta-analysis of RET-targeted therapies. [PDF]

Front Endocrinol (Lausanne)
Wang J, Cao G, Liu Y, Qiao H, He Q, Zheng B.   +5 more
europepmc   +1 more source

Induction therapy of pralsetinib followed by conversion surgery for unresectable locally advanced non-small cell lung cancer with the rearranged during transfection (RET) fusion gene mutation: protocol for a single-arm phase II prospective trial (the SALVAGE-P trial). [PDF]

J Thorac Dis
Deng HY, Qiu XM, Li L, Tang XJ, Zhou Q.
europepmc   +1 more source

The dual axis of tumorigenesis: MAPK and PI3K/AKT pathways in papillary thyroid carcinoma. [PDF]

Oncoscience
Rathod G, Parmar P.
europepmc   +1 more source

Development and Characterization of a Patient-Derived <i>KIF5B-RET</i> Fusion Lung Adenocarcinoma Cell Line for Subcutaneous and Central Nervous System Tumor Models in Immunodeficient Mice. [PDF]

JTO Clin Res Rep
Nishiyama A, Sato S, Sakaguchi H, Kotani H, Yamashita K, Ohtsubo K, Nanjo S, Yano S, Mizuguchi K, Ikeda H, Yamaguchi M, Ishizuka T, Baba S, Takeuchi K, Takeuchi S.   +14 more
europepmc   +1 more source

<i>RET</i> fusion partners dictate oncogenic potential in undifferentiated spindle cell sarcomas. [PDF]

Cancer Biol Ther
Gui Q, Zhang Y, Yang M, Liang R, Huang M, Yang X, Chen N, Chen X, Wu M, Chen H, Meng L, Xiao S, Tao M.   +12 more
europepmc   +1 more source